{site_meta && site_meta.display_name} Logo

Reportable

Cut through the daily deluge of information from news, social media and scientific literature to better communicate to your audiences, monitor and measure your business reputation and keep a close eye on your competition.

RSS Feed for Reportable

Wendt Partners Expands Toronto Office to Support Canadian Growth

October 31, 2025October 28th, 2025, New York, NY- Wendt Partners is excited to announce the relocation and exposition of it's Toronto office as part of the Company's ongoing growth across Canada. Our new space at 180 John Street, just off Queen Street West in Old Toronto, places us right in the heart of the city’s creative and business community, just ten minutes from Union Station via TTC Line 1.


Boldin Survey Finds Retirement Unknowns Are Scarier Than a Halloween Night in the Woods

October 29, 2025San Francisco — October 29, 2025 — Boldin, the financial confidence company, today revealed the results of its retirement fears survey. Of the more than 1,000 financially savvy Americans polled, 66% said that before they had a plan, their retirement fears felt scarier than walking alone in the woods on a dark Halloween night.


UGI Expands Efforts to Stop Scammers from Deceiving Utility Customers

October 28, 2025FOR IMMEDIATE RELEASERelease Date: October 28, 2025UGI continues to spread awareness of scammers targeting utility customers, but the scammers are not stopping their aggressive tactics to target and deceive customers. UGI is reaching out to law enforcement departments to make them aware of the scams and in hopes the departments will also alert the public.


Lifordi Immunotherapeutics Presents Nonclinical Data on Glucocorticoid Antibody Drug Conjugate LFD-200 at ACR 2025 and Initiates Phase 1 Study in Rheumatoid Arthritis

October 27, 2025BURLINGTON, MA – October 27, 2025 -- Lifordi Immunotherapeutics, Inc. , a clinical-stage biotech company developing antibody-drug conjugates (ADCs) for the treatment of autoimmune and inflammatory disorders, presented nonclinical data on its lead LFD-200, an ADC delivering a potent glucocorticoid (GC) directly to immune cells.


UGI Offers Heating System Checklist as Colder Weather Arrives

October 17, 2025With cooler temperatures here, many people are turning the heat on in their home or at least considering it.  UGI’s commitment to deliver safe and reliable energy services this heating season is dependent on proper system maintenance and safety checks.


Canadian Club devient partenaire officiel de Soccer Canada et de la Première ligue canadienne

October 16, 2025TORONTO (Ontario) – le 16 octobre 2025 – Canadian Club rejoint la formation de départ en tant que partenaire officiel de Soccer Canada et de la Première ligue canadienne. Cette alliance marque le début d’un partenariat de trois ans avec l’organe directeur national du soccer et la ligue professionnelle masculine du pays, à un moment où le sport connaît une croissance sans précédent au Canada et fait vibrer les cœurs d’un océan à l’autre.


Canadian Club Signs on as Official Partner of Canada Soccer and Canadian Premier League

October 16, 2025TORONTO, ON – October 16, 2025 – Canadian Club has joined the starting lineup as an Official Partner of Canada Soccer and the Canadian Premier League. This marks the beginning of a spirited three-year partnership with soccer’s national governing body and its domestic men’s professional league at a time when the sport is experiencing unprecedented growth in Canada and igniting hearts across the country.


Stonegate Capital Partners Initiates Coverage on Pensana PLC (LSE: PRE)

October 16, 2025DALLAS, TX -- October 15th, 2025 -- Pensana PLC (LSE: PRE): Stonegate Capital Partners initiates their coverage on Pensana PLC (LSE: PRE). Pensana is one of the few developers outside China pursuing a full mine-to-magnet model, capturing value across the rare earth supply chain.


From the Bandarian Lab to a Utah Spinout: University of Utah Science Powers Enzymatic Makeovers for GLP-1-Like Peptides

October 14, 2025SALT LAKE CITY, October 14, 2025 — A University of Utah team has shown that a radical enzyme can "tie off" therapeutic peptides into compact rings without the usual leader-sequence requirements, an advance now moving from campus to clinic-facing development through Utah spinout Sethera Therapeutics. The findings have been published in a paper in the prestigious ACS Bio & Med Chem Au Journal.